What to Make of the FDA's Latest Warning to AbbVie and Pfizer

[cafead]

via

• The FDA placed additional warnings on AbbVie's Rinvoq and Pfizer's Xeljanz.
• Xeljanz received a tougher warning than Rinvoq did.
• The worst-case scenario is that the FDA opts to restrict higher doses of the two JAK inhibitors.

article source